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Abstract—The fur gene encodes the endoprotease, furin. We recently demonstrated mutations in
both fur alleles in the mutant Chinese hamster ovary (CHO)-K1 strain, RPE.40, and hypothesized
that these mutations were responsible for the endoprotease-deficient phenotype of these cells. We
now present the structural and functional properties of three protein products derived from the
mutant fur alleles. None of these protein products were able to process the precursor to von
Willebrand factor, which is processed by wild-type furin. Pro-protein processing activity initially
attributed to one of the mutant proteins was due to wild-type furin produced inadvertently from one
of the expression constructs used in these experiments. None of the mutant proteins exhibited
evidence of autocatalysis, consistent with the lack of activity versus the test substrate, and
glycosylation patterns suggested at least two of them remained in the endoplasmic reticulum. These
results confirm that RPE.40 cells are furin null mutants, as earlier evidence had suggested.
INTRODUCTION
A number of mammalian subtilisin-like
endoproteases have recently been discovered (1,
2). The prototype of these enzymes is furin, a
calcium-dependent, ubiquitously expressed en-
doprotease that has been shown to process a
number of mammalian pro-proteins, viral glyco-
proteins, and bacterial toxins at the consensus
sequence Arg-X-Lys/Arg-Arg (3–16). Furin is
synthesized as an inactive precursor and under-
goes autocatalytic activation (17, 18). Furin is
primarily localized in the trans-Golgi network
(TGN) (4, 19-21), although it also appears to
cycle between the TGN and the cell surface
(20); secreted forms of furin, produced by an as
yet uncharacterized carboxy-terminal cleavage,
have also been identified (20, 22-24).
The physiological role of furin in process-
ing pro-proteins has generated considerable
interest. Among the most useful tools used to
address this issue have been mutant cell strains
that do not express furin. One such cell strain
has been developed in our laboratory by
mutagenizing Chinese hamster ovary cells
(CHO-K1) with ethyl methane sulfonate (EMS).
This cell strain, RPE.40, was initially selected
for resistance to Pseudomonas exotoxin A
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(PEA; 25). It was subsequently shown that the
resistance of RPE.40 cells to PEA is due to an
inability to proteolytically cleave and activate
PEA (26). RPE.40 cells are also resistant to
several alphaviruses, due to an inability to
proteolytically process the viral envelope glyco-
proteins (27, 28). Additionally, RPE.40 cells are
unable to process several other precursor
proteins, including the endogenous low-density-
lipoprotein receptor-related protein and the
endogenous insulin proreceptor (15, 29). Expres-
sion of a mouse furin cDNA in RPE.40 cells
restored wild type characteristics (29, 30).
Hybridization of RPE.40 cells with LoVo cells,
endoprotease deficient cells with characterized
mutations in their fur alleles (31, 32), showed
that the lesion(s) in both cell types was in the
same genetic locus (26). We therefore concluded
that the mutation(s) responsible for the RPE.40
phenotype was at the fur locus.
We recently reported that both CHO-K1
and RPE.40 cells express mRNAs from two fur
alleles (33). In CHO-K1 cells, the only differ-
ence between the two alleles is manifested at
codon 196: one allele encodes a cysteine (cys196)
while the other encodes a tyrosine (tyr196). The
cysteine at position 196 is conserved in all other
mammalian furins examined to date (5, 34–40),
and may be involved in forming a disulfide
bridge with cysteine 226 (12). We hypothesized
that the allele encoding cys196 produced a
functional furin protein, while the functionality
of the tyr196 protein was suspect. In RPE.40
cells, full length cDNAs encoded only tyrl96
furins, while cDNAs encoding cys196 were
synthesized only from mRNAs exhibiting at
least two defective exon-splicing patterns, re-
ferred to as cysl96dsI and cysl96dsII. Neither
defectively spliced mRNA could direct the
translation of a full length protein product. We
concluded that the tyrosine codon was the result
of a pre-existing background mutation found in
a subset of CHO-K1 cells, and the EMS-induced
mutation leads to the defective splicing of
mRNAs derived from the cysteine encoding
allele. We now report that the expression of a
full length cDNA encoding cys196 in RPE.40
cells resulted in the production of active furin,
while the expression of a tyrl96-encoding cDNA
resulted in the production of furin protein unable
to process a test substrate. We also show that
proteins translated from the defectively spliced
mRNAs cannot process a test substrate. We have
also examined some other characteristics of these
allelic products, including autocatalytic and glyco-
sylation patterns, and showed that the function of
the allelic products, or the lack thereof, largely
correlates as expected with these characteristics.
These results confirm that RPE.40 cells are furin
null mutants, as earlier data had suggested.
MATERIALS AND METHODS
Materials, Tran35S-label was purchased
from ICN Biochemicals (Costa Mesa, Califor-
nia). PshAI was purchased from Amersham/
USB (Cleveland, Ohio); all other restriction
enzymes were purchased from Gibco-BRL
(Gaithersburg, Maryland). Calf intestinal alka-
line phosphatase was also purchased from
Gibco-BRL. T4 DNA ligase was obtained from
Boehringer Mannheim (Indianapolis, Indiana).
Western blotting reagents were purchased from
Promega (Madison, Wisconsin). The construct
encoding the precursor to von Willebrand factor
was generously provided by Drs. Jan A. van
Mourik and Jan Voorberg of the Central
Laboratory of the Netherlands Red Cross Blood
Transfusion Service. Unless otherwise indicated, all
other reagents were obtained from the Sigma
Chemical Company (St. Louis, Missouri).
Cell Culture. CHO-K1 cells were pur-
chased from the American Type Culture Collec-
tion (Rockville, Maryland). The generation of
RPE.40 cells has been previously described
(25). Cells were cultured in Dulbecco’s modi-
fied Eagle medium/Ham’s F-12 medium contain-
ing 5% fetal bovine serum (hereafter referred to
as growth medium) at 37°C in an atmosphere of
5% CO2 in air.
Construction of the Expression Plasmids.
The PCR amplification and cloning of the furin
cDNAs has been described previously (33). The
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cDNAs were cloned into the mammalian
expression vector pcDNA3 (Invitrogen; Carls-
bad, CA); to simplify terminology, the con-
structs are referred to in the text by the cDNA
they carry, i.e., cys196 or cysl96dsI. Domain swap
constructs were generated by subjecting con-
structs harboring full length cys196 or tyr196
cDNAs to digestion with Eco81I and StuI. Two
fragments containing codon 196 were recovered
and purified following digestion. The Eco81I/
StuI fragments were then reintroduced into the
plasmids, but the fragment encoding cys196 was
inserted into the plasmid originally containing
the tyr196 codon, while the fragment encoding
tyr196 was inserted into the plasmid originally
containing the cys196 codon. Sequencing analy-
sis confirmed the codon present at position 196
in the domain swapped plasmids.
Transfections. Approximately 1 × 106
RPE.40 cells were seeded in 3 ml growth
medium in 60 mm X 15 mm tissue culture
dishes and incubated for 16 hr before transfec-
tions were initiated. Transfections were done
with the Lipofectamine reagent (Gibco-BRL)
according to the manufacturer's instructions; 3
mg DNA were used for the transfections, and 3
mg of each construct were used for co-
expression experiments. Following transfec-
tions, the cells were washed once with Dulbec-
co’s phosphate buffered saline (PBS) and then
were incubated in either growth medium (for all
radiolabeling experiments) or in HyQ-CCM5
serum-free medium, obtained from Hyclone
Laboratories, Inc., Logan, Utah (for co-
expression experiments in which the processing
of pro-vWF was assayed).
Western Blotting to Analyze pro-vWF
Processing. Conditioned HyQ-CCM5 medium
from cells co-transfected with the furin and
pro-vWF constructs was collected 60 hr post
transfection. Samples of the medium were
subjected to SDS-PAGE (5% or 7.5% gels under
reducing conditions) and the resolved proteins
were transferred to Immobilon-P membranes
(Millipore). The membranes were blocked for
1 h with 2% milk in PBS, then incubated
overnight with anti-vWF antibody (Dako Corpo-
ration, Carpinteria, California) diluted 1:2500 in
0.6% milk-PBS. The membranes were washed
3 X (3 min each) with 0.6% milk-PBS, blocked
for an additional 30 min, and subjected to an
anti-rabbit IgG alkaline phosphatase conjugate
(diluted 1:5000 in 0.6% milk-PBS) for 1.5 hr.
After two more washes in 0.6% milk-PBS and
one in substrate buffer (0.1 M Tris [pH 9.5], 0.1
M NaCl, 5 mM MgCl2), each for 3 min, color
development was initiated by adding 40 ul nitro
blue tetrazolium (50 mg/ml) and 20 ul 5-bromo-4
chloro-3-indolyl-l-phosphate (50 mg/ml) into
20 ml substrate buffer and placing this mixture
on the membrane.
Metabolic Labeling and Immunoprecipi-
tations. Metabolic labeling was used to analyze
furin proteins expressed from the recombinant
fur cDNAs. Cells transfected with fur constructs
were incubated for 40 hr in growth medium,
then starved for cysteine and methionine for 30
min in Dulbecco's modified Eagle medium
without L-cysteine, L-methionine, or fetal bo-
vine serum (hereafter referred to as labeling
medium). This medium was removed and
labeling medium containing 200 uCi 35S-amino
acids (Tran35S-label, ICN Biochemicals) per 60
mm X 15 mm dish was then added. Labelings
were done either as pulses or as pulse-chase
experiments; for pulse-chase experiments, the
labeling medium was removed after the pulse
and replaced with growth medium for the chase.
The times of pulses and chases varied from
experiment to experiment, and the Figure
Legends contain information for the individual
experiments. Following the labeling, cells were
lysed by adding 500 ul Lysis Buffer (50 mM
Tris-HCl [pH 8.0], 0.15 M NaCl, 1% Triton
X-100, 0.5% sodium deoxycholate, 0.1% SDS)
per 60 mm X 15 mm dish and incubating for 10
min on ice. The lysate was centrifuged for 5 min
(10,000 X g) at 4° to remove cellular debris.
The lysate was precleared by adding 50 ul
protein-A-sepharose beads (Sigma) and incubat-
ing overnight at 4° with gentle rocking.
Immunoprecipitations were set up on the
pre-cleared lysates by adding 2-5 ul of an
anti-furin serum, kindly provided by Dr. Steven
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Smeekens and Jane R. Goldman of the Chiron
Corporation (Emeryville, California), diluted
1:10 with PBS. The immunoprecipitations were
incubated overnight at 4° with gentle agitation.
Protein-A-sepharose was added (10 ul), incu-
bated at 4° with gentle agitation for 1.5 hr, and
the beads were pelleted and washed with Lysis
Buffer three times. After the third wash, the
beads were pelleted again, and immunoprecipi-
tated proteins were eluted from the protein-A/
antibody complex by heating to 95° for 3 min in
SDS-PAGE sample buffer (41). The eluted
proteins were subjected to SDS-PAGE. The gels
were stained with Coomassie blue, dried using a
Savant gel dryer, and immunoprecipitated pro-
teins were analyzed by autoradiography using
Kodak X-ray film. To detect and analyze
secreted furin, the immunoprecipitations were
carried out on conditioned medium from labeled
cells; an equal volume of Lysis Buffer was
added to each medium sample prior to pre-
clearing and immunoprecipitation.
Treatment of Furin Proteins with Endogly-
cosidase H and N-Glycanase. All reactions that
included endoglycosidase H and N-glycanase
were done on immunoprecipitated furin pro-
teins. Immunoprecipitations were done as de-
scribed above, except that the immunoprecipi-
tated proteins were not eluted in SDS-PAGE
sample buffer. For treatment with N-glycanase,
the immunoprecipitated proteins were eluted
from the beads by resuspending the beads in 10
ul 0.2 M Tris-HCl (pH 8.0), 0.5% SDS, 50 mM
b-mercaptoethanol, and heating to 75°C for 5
min; 5 ul 7.5% NP40 were added, the beads
were pelleted by pulsing for 5 sec in a
microcentrifuge, the supernatant was transferred
to a new tube, and 1.2 ul N-Glycanase
(Genzyme), corresponding to approximately 0.3
units, were added. The total reaction volume
was brought up to 30 ul by the addition of 13.8
ul water, and the reactions were incubated at 37°
for at least 16 hr. To treat samples with
endoglycosidase H (endo-H), the immunopre-
cipitated proteins were eluted from the beads by
resuspending the beads in 10 ul 0.5% SDS and
heating to 75°C for 5 min. The beads were then
pelleted by pulsing the sample for 5 sec in a
microfuge; the supernatant was transferred to a
new tube, 19 ul 50 mM sodium phosphate (pH
6.0) were added, and 1 ul endo-H (Genzyme)
was added. The reactions were incubated at 37°
for at least 16 hr. After the incubations,
SDS-PAGE sample buffer was added, the
samples were heated to 95°C for 3 min, and then
subjected to SDS-PAGE. SDS gels were stained
with Coomassie blue, dried, and subjected to
autoradiography using Kodak X-ray film. Trans-
ferrin and ovalbumin were used as positive controls
for N-Glycanase and endo-H activity, respectively.
RESULTS
Proprotein Processing Activity of the fur
Allelic Products. Figure 1 summarizes the
putative fur allelic products produced in RPE.40
cells (33). We cloned cDNAs encoding each of
these potential protein products, along with the
domain swapped constructs, into the mamma-
lian expression vector pcDNA3. These con-
structs were co-transfected into RPE.40 cells
along with a construct directing the expression
of the precursor to von Willebrand factor
(pro-vWF). To analyze the processing of the
pro-vWF, proteins secreted from transfected
cells were analyzed by western blotting, as
shown in Fig. 2. Processed vWF was secreted
from cells expressing the full length cys196
protein, the tyr196—>cys196 protein, and the
cys196dsI protein; pro-vWF was secreted from
cells expressing the tyr196, cys196—»tyr196, and
cys196dsII proteins. These data suggested that the
cys196 protein was catalytically active, while the
tyr196 protein was inactive. Since the results
obtained with the domain swap constructs were
the same as those obtained with the legitimate
cys196 and tyr196 proteins, the inactivity of furin
proteins containing a tyrosine at position 196 is
directly attributable to the mutation that changed
the cysteine codon at position 196 to a tyrosine
codon. Cells transfected with the cysl96dsI
construct also processed pro-vWF, while cells
transfected with the cysl96dsII construct did not
process pro-vWF. The result obtained with
cys196dsI was somewhat of a surprise, as we did
not expect furin activity to be associated with any of
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Fig. 1. Summary of the Allelic Products Expressed from the fur Locus in CHO-K1 and RPE.40 Cells. Schematic representation of
RPE.40 and CHO-K1 fur cDNAs and deduced protein structures. (A) The middle structure represents cDNAs derived from correctly
spliced mRNAs, while the cys196dsI and cys196dsII cDNAs are shown above and below, respectively. Exons designated A-E represent
cDNA segments known to follow proper exon/intron splice junctions; all of the junctions in the CHO-K1 fur gene are not accounted
for in the diagrams. Introns, or portions thereof, are shown as straight lines. The sizes of the cDNAs are indicated at the end of each
diagram. Location of the translation stop codon (TGA) is indicated for each cDNA. The location of codon 196, encoding either,
cysteine or tyrosine, is shown in the middle diagram. (B) The deduced furin protein structures are presented in the same order as the
cDNA structures. The catalytic and Homo B domains are indicated, while abbreviations are used to designate the signal peptide (SP),
pro-peptide (PRO), cysteine-rich domain (CRD), and transmembrane domain (TD). The locations of the active site aspartate, histidine,
and serine amino acids, the putative substrate-binding asparagine, and codon 196 are shown within the catalytic domain. The site of
autoproteolytic removal of the propeptide is indicated by RTKR. The initiating methionine is designated –107; the first amino acid in
the mature protein is +1. The blackened area within the Homo B domain represents the region containing amino acids 449–469,
which appear to be essential for furin activity. The total number of exon-encoded deduced amino acids for each furin are indicated. The
intron-encoded deduced amino acids are shown extending beyond the diagram of the exon-encoded structures. Reproduced from (33)
with permission.
the mutant proteins, given the phenotype of RPE.40
cells and the fact that the cys196dsI protein lacks an
intact Homo B domain, a region of furin proteins
believed to be essential for activity.
Structural Analysis of the Full Length
Allelic Products. We next turned to an examina-
tion of structural characteristics of the furin
proteins. We were particularly interested in
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Fig. 2. Coexpression the fur Allelic Products and pro-vWF in RPE.40 Cells. Expression vectors carrying cDNAs for the fur
allelic products and pro-vWF were introduced into cells following the transfection procedure described in Materials and
Methods. At 60 hr post transfection conditioned medium was collected from the transfected cells, and the state of vWF
secreted into the medium was analyzed by western blotting. Lanes 1 and 2 are controls in which pro-vWF alone was
expressed in either CHO-K1 cells (Lane 1) or RPE.40 cells (Lane 2). In the remaining lanes, pro-vWF was coexpressed in
RPE.40 cells with constructs directing the expression of full length cys196 furin (Lane 3), full length tyr196 furin (Lane 4),
tyr196_cys196 furin (Lane 5), cys 1 9 6 - tyr 1 9 6 furin (Lane 6), cys196dsI furin (Lane 7), and cys196dsII furin (Lane 8). The
arrowhead indicates the position of pro-vWF, while the arrow indicates the position of mature vWF.
correlating the processing of pro-vWF by the
expressed furins with 1) their autocatalytic
processing and 2) their pattern of glycosylation,
two characteristics which could provide insight
into the cellular localization of the furins and the
biochemical basis for the processing, or lack
thereof, by the furin proteins.
Figure 3 shows the autocatalytic properties
of the full length allelic products and the
"domain swapped" full length proteins. Autoca-
talysis was examined by transient transfection,
pulse-chase labeling, immunoprecipitation, and
SDS-PAGE/autoradiography. Furin proteins con-
taining cys196 were immunoprecipitated as a
doublet with molecular weights of approxi-
mately 100 and 110 kDa. This doublet decreased
in intensity over the time course of the chase.
Furin containing tyr196 was immunoprecipitated
as a single band that co-migrated with the higher
molecular weight member of the cys196 doublet
and did not decrease in intensity over the time
course of the chase. These data suggest the
cys196 and tyr196—»cys196 proteins underwent
autocatalytic processing, indicated by the dou-
blet, and also underwent turnover, as reflected in
the decreasing intensity of the bands during the
chase period; similar results have been obtained
by others examining furin (12, 19, 24, 42). The
tyr196 proteins did not undergo autocatalysis, as
only a single band was observed after immuno-
precipitation with anti-furin antibodies. Thus,
the substitution of tyrosine for cysteine at
position 196 blocked autocatalytic activation.
The tyr196 proteins also did not turnover, as the
tyr196 bands did not decrease in intensity during
the time course of the chase. Presumably, the
lack of turnover of the tyr196 protein is linked to
the lack of autocatalysis, as reports suggest
profurin molecules remain trapped in the
endoplasmic reticulum (20, 23, 43) and would
thus not traverse the same pathway as wild-type
furin; we will address this issue below.
Figure 4 shows patterns of glycosylation of
the full length allelic products. Radiolabeled
cys196 or tyr196 proteins were immunoprecipi-
tated and then treated with endoglycosidase-H
(endo-H), which removes co-translationally
added high mannose sugars, or N-glycanase,
which removes all attached sugars, including the
endo-H resistant complex oligosaccharides added
in the Golgi complex. The treated proteins were
then resolved by SDS-PAGE, and the results
were visualized by autoradiography. The top
panel shows the results obtained with cys196 pro-
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Fig. 3. Analysis of the Autocatalytic Processing of Cys196 and Tyr196 Full Length Allelic Products. Expression plasmids
carrying cDNAs for the cysl96 and tyr196 full length furin products, and the domain swapped cys196—-tyr196 and tyr196—>cys196)
furins, were introduced into RPE.40 cells as described in Materials and Methods. At 36 hr post transfection metabolic
labeling was initiated; the transfected cells were pulse-labeled for 30 min, followed by chases of 1 hr, 2 hr, 3 hr, or 4 hr
(indicated by 1,2,3, or 4). After the labeling, cells were lysed and furin proteins were immunoprecipitated. The
immunoprecipitated proteins were resolved by SDS-PAGE and visualized by autoradiography. The upper panel shows results
obtained with the full length cys196 furin and full length tyr196 furin. The lower panel shows results obtained with the
tyrl96->cys196 furin and the cysl96–>tyrl96 furin. The arrows indicate the positions of 116 kDa and 92 kDa molecular weight
markers. The lower molecular weight protein seen in these figures is non-specifically immunoprecipitated from RPE.40 cells.
teins. Endo-H treatment separated the cys196
doublet into three distinct bands. Based on the
results obtained in other studies (23, 43), these
three bands probably represent (in order of
decreasing apparent molecular weight): 1) auto-
catalytically processed furin that has moved into
the Golgi complex and has acquired endo-H
resistant complex oligosaccharides; 2) pro-
peptide containing furin stripped of high man-
nose sugars by endo-H; and 3) autocatalytically
processed furin that has not yet moved to the
Golgi complex, and thus was stripped of high
mannose sugars by endo-H. N-glycanase treat-
ment resolved these three bands into two protein
species, which co-migrated with the two lowest
molecular weight bands generated by endo-H
treatment. This result is consistent with our
interpretation of the endo-H data, since autocata-
lytically processed, endo-H resistant furin should
be sensitive to N-glycanase. The bottom panel
shows the results obtained when identical
experiments were done on the tyr196 protein. The
apparent molecular weight of this protein was
shifted downward to an equal extent by both
endo-H and N-glycanase treatment, indicating
the presence of only high mannose sugars. The
data presented in Figure 4 are consistent with
our contention that only the cys196 protein
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Fig. 4. Glycosylation of the Cys196 and Tyr196 Furin Proteins. The full length cys196 and tyrl96 containing furins were
expressed in RPE.40 cells as described in Materials and Methods. Proteins were labeled with a 4 hr pulse of 35S-amino acids,
then furin proteins were immunoprecipitated and treated with either endoglycosidase H (endo-H), which removes
cotranslationally added high mannose sugars from glycoproteins, or N-glycanase, which removes all attached sugar moieties
from glycoproteins. The treated proteins were resolved by SDS-PAGE and visualized by autoradiography. Lanes marked —
represent untreated controls. Lanes labeled H represent samples treated with endo-H, while Lanes marked N contain samples
treated with N-glycanase. The identity of the amino acid at position 196 is indicated as either cysteine or tyrosine. The arrows
indicate the positions of 116 kDa and 92 kDa molecular weight markers.
moves from the endoplasmic reticulum to the
Golgi complex, as only this protein acquired the
complex oligosaccharides added in the Golgi
complex. The results shown in Fig. 4 are also
consistent with our hypothesis that only the
cys196 protein undergoes autocatalytic activa-
tion. Results of experiments in which the
domain swapped products were subjected to
endo-H and N-glycanase treatment were identi-
cal to the results obtained with the "original"
proteins; only proteins containing cys196 exhib-
ited evidence of autocatalysis and endo-H
resistance (data not shown).
Structural Analysis of the cys196dsI and
cys196dsII Proteins. Figure 5 shows the results of
our initial examination of the autocatalytic
properties of the cys196dsI and cys196dsII proteins.
These proteins were analyzed by transient
transfection and metabolic labeling, as de-
scribed for the full length proteins above.
However, because the truncated proteins result-
ing from the translation of the defectively
spliced mRNAs would lack a transmembrane
domain (Fig. 1), and because such furins can be
secreted (7, 42), cell lysates as well as
conditioned media were examined for the
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Fig. 5. Examination of the Autocatalytic Properties of the Cys196dsI and Cys196dsII Furin Proteins. The cys196dsI and cysl96dsII
proteins were expressed in RPE.40 cells as described in Materials and Methods. Proteins were labeled with a 30 min pulse of
35S-labeled amino acids followed by a chase of either 4 hr or 14 hr. Furin proteins were then immunoprecipitated from either
cellular lysates or samples of conditioned medium. The upper panel shows results obtained with the cys196dsI protein; the
lower panel shows results obtained with the cys196dsII protein. Immunoprecipitations were done from lysates or medium, as
indicated. Lanes labeled P were immunoprecipitated from samples pulse labeled for 30 min. Lanes labeled 4 were
immunoprecipitated from samples chased for 4 hr after the 30 min pulse. Lanes labeled 14 were immunoprecipitated from
samples chased for 14 hr after the 30 min pulse. Arrows represent the positions of molecular weight markers. The protein just
above the 75 kDa marker is non-specifically immunoprecipitated from RPE.40 cells.
presence of furin proteins in these experiments.
Immunoprecipitations from lysates derived from
cells transfected with the cys196dsI construct
exhibited a prominent band of approximately 72
kDa, while immunoprecipitations from lysates
derived from cells expressing cys196dsII showed a
doublet with bands of approximately 50 and 54
kDa. These results suggest the truncated furins
do not undergo autocatalytic activation, for no
doublet was observed for the cys196dsI protein
and the size heterogeneity observed for the
cys196dsII doublet was not sufficient to be
attributed to propeptide removal. Also, the
observed molecular weights approximate the
calculated molecular weights determined for
cys196dsI (75 kDa) and cys196dsII (56 kDa) proteins
with propeptides. Analysis of medium samples
from cells transfected with the cysl96dsI plasmid
revealed a protein of approximately 85 kDa,
suggesting a form of secreted furin was
produced by these cells. The medium from cells
transfected with pcDNA3-cys196dsII showed no
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proteins immunoprecipitated by the anti-furin
antibodies, indicating that no secreted form of
furin was produced by these cells.
The results obtained with cys196dsI raised
some obvious concerns. First, we saw no
evidence of autocatalytic activity in the immuno-
precipitated cys196dsI protein, as only a single
band was observed. We had expected to see
evidence of autocatalysis, since coexpression of
the cys196dsI protein with pro-vWF had resulted
in the production of mature vWF (Fig. 2).
Second, the protein immunoprecipitated from
medium samples was almost 15 kDa larger than
the protein observed in the cell lysates. While
glycosylation can increase the apparent molecu-
lar weight of a protein, a nearly 15 kDa shift
seemed unreasonable considering that the com-
plete glycosylation of full length furin results in
an apparent molecular weight increase of 10
kDa or less (23, 42, Fig. 4). These inconsisten-
cies led us to reevaluate some of our data and
materials. The nature of the cDNA used to make
the cys196dsI expression construct quickly be-
came a source of concern. This cDNA was made
from the defectively spliced cys196dsI mRNA and
contains the sequence of the intact, normal
intron inserted between what we have desig-
nated furin exons C and D (Fig. 1). We
speculated that at least some of the RNA
transcribed from this construct might have the
intron properly removed, resulting in the correct
splicing of a full-length, cys196 furin mRNA in
the transfected cells. Indeed, the cys196dsI lysate
immunoprecipitations in Fig. 5 show what could
be a full length furin doublet running at
approximately 100 kDa. We further speculated
that if some correct splicing of these mRNAs
was occurring, then 1) the pro-vWF processing
activity we had observed in the cys196dsI
transfectants was the result of full-length, cys196
furin, and 2) the 85 kDa protein observed in the
medium from these transfected cells was soluble
furin, presumably derived from a carboxy-
terminal truncation of full length furin mol-
ecules (18, 20, 22-24). We tested these hypoth-
eses as described below.
To examine whether some full length furin
protein was being synthesized, truncated, and
secreted from cells transfected with the cysl96dsI
construct, we carried out a transfection and
labeling experiment to compare the products
derived from both cys196 and cysl96dsI constructs.
We examined furin proteins in both the lysates
and in the medium from these transfected cells,
and examined their glycosylation characteris-
tics. These results are shown in Fig. 6. The cells
transfected with the cysl96dsI expression plasmid
clearly produce two furin proteins. The larger of
these proteins co-migrates as a doublet with the
full-length furin doublet derived from cells
expressing the cysl96 furin. The 85 kDa protein
immunoprecipitated from the conditioned me-
dium of cells transfected with the cys196dsI
construct co-migrates with a protein derived
from the conditioned medium of cells express-
ing the cys196 protein. These data provided
strong evidence that some of the mRNA
transcribed from the cys196dsI construct was
being correctly spliced, and suggested that the
activity we had attributed to the cys196dsI protein
is the result of full length furin derived from a
population of correctly spliced mRNAs in the
cys196dsI-transfected cells.
To prove that full length furin molecules
produced by cells transfected with the cysl96dsI
construct were the result of correctly spliced
mRNAs, we created an alternate expression
plasmid in which the intact intron was removed.
The generation of the alternate construct is
shown in Figure 7. Briefly, the original cysl96dsI
expression plasmid was digested with PshAI,
an enzyme which cut the construct just down-
stream of the stop codon encoded in the intron,
and EcoRV, which cut in the multiple cloning site of
pcDNAS just downstream of the cloned cDNA.
Both of these restriction enzymes generate blunt
ends, and the construct was religated following a
gel purification step to remove the small
fragment containing the 3' intron and cDNA
sequences. The resultant plasmid contained all
of the sequence information necessary to make
the truncated cys196dsI protein, but lacked the
complete intron sequence and the 3' end of
the full length cDNA contained in the original
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Fig. 6. Comparison of Proteins Expressed from Plasmids Encoding the Cys196 and Cys196dsI Furins. Expression plasmids
encoding either the full length cys196 furin or the cys196dsI furin were introduced into RPE.40 cells. Expressed furin proteins
were labeled for 16 hr with 35S-labeled amino acids and immunoprecipitated from either cell lysates (L) or conditioned
medium (M). One sample of each immunoprecipitate was treated with N-Glycanase (+), while a second was untreated (—).
The arrows represent the positions of molecular weight markers. The protein just above the 75 kDa marker is non-specifically
immunoprecipitated from RPE.40 cells.
construct. The nomenclature assigned to the
new construct and its cDNA was cys196dsI-a.
Furin proteins expressed from this construct
were then analyzed by transfection and meta-
bolic labeling, and compared to the furin
proteins expressed from the cys196dsI construct.
These results are shown in Figure 7 (middle
panel). The cys196dsI-a construct directed the
synthesis of a 72 kDa protein found only in the
lysate. Full length furin proteins and the 85 kDa
medium protein were expressed only in cells
transfected with the cys196dsI construct, as
hypothesized. We then examined the ability of
the truncated protein expressed from the cys196dsI-a
construct to process pro-vWF. Figure 7 (bottom
panel) shows that cells co-transfected with
cys196dsI-a and the pro-vWF expression plasmid
secreted only pro-vWF, while cells co-trans-
fected with the cys196dsI and pro-vWF constructs
secreted mature vWF. Figures 6 and 7 thus
provide conclusive evidence that: 1) the activity
we had earlier attributed to the cys196dsI protein
was in fact due to full length, cys196 furin
translated from correctly spliced mRNAs de-
rived from the cys196dsI construct; 2) the 72 kDa
protein represents the translation product of
legitimate cys196dsI mRNAs; and 3) the 72 kDa
protein is not catalytically active.
To further analyze the cys196dsI (expressed
from the cys196dsI-a construct) and cys196dsII
proteins we examined their glycosylation charac-
teristics (Fig. 8). Endo-H treatment indicated
both proteins contained high mannose oligosac-
charides. The shift in molecular weight was less
than that obtained with endo-H treatment of full
length furin molecules, indicative of the likely
loss of glycosylation sites in the truncated
proteins (Fig. 1). The cys196dsI doublet is
apparently the result of inconsistent addition of
high mannose sugars to individual protein
molecules, as the endo-H treatment abolishes
the size heterogeneity observed in the immuno-
precipitated protein. N-glycanase treatment of
the cys196dsI protein caused a larger molecular
weight shift than treatment with endo-H, suggest-
ing that complex oligosaccharides are a compo-
nent of this protein's complement of sugars.
This result was somewhat unexpected, but may
be attributable to the nature of the cys196dsI
molecule (discussed further). The apparent
molecular weight of the cys196dsII protein is
identically altered by both endo-H and
Fig. 7
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Fig. 8. Glycosylation of the Cys196dsI and Cys196dsII Furin Proteins. RPE.40 cells were transfected with expression plasmids
encoding either the cys196dsI (the cys196dsI-a construct) or cys196dsII proteins. Proteins were labeled with 35S-amino acids 36 hr
post transfection, and furin proteins were immunoprecipitated from cell lysates. Samples of each immunoprecipitated protein
were treated with endo H (lanes marked H) or N-glycanase (lanes marked N); samples in lanes marked with a C were
untreated controls exposed to neither enzyme. Results were analyzed by SDS-PAGE and autoradiography. Arrows mark the
positions of the indicated molecular weight standards. The protein just above the 75 kDa marker is non-specifically
immunoprecipitated from RPE.40 cells.
N-Glycanase, indicating only high mannose
sugar groups are attached to this molecule.
DISCUSSION
RPE.40 cells are deficient in an endoprote-
ase activity. We have compiled considerable
evidence indicating that the genetic lesion(s) in
these cells are in both alleles of the fur gene (29,
30, 33). We recently demonstrated that two fur
alleles are expressed in RPE.40 cells and
showed that each allele in these cells harbors a
mutation (33). In one allele, a background point
mutation results in a tyrosine codon rather than
the wild-type cysteine codon at position 196,
The other allele encodes cysteine at position
196, but an unidentified EMS-generated point
mutation causes the defective splicing of
mRNAs. The defectively spliced mRNAs can be
translated into truncated furin proteins. In this
study, co-expression experiments were utilized
to demonstrate that furin proteins manifesting
these mutations are not catalytically active. This
finding conclusively proves that RPE.40 cells
are furin null mutants. Our studies, and those of
others, provide insight into the underlying
Fig. 7. Preparation of the Cys196dsI-a Construct and Analysis of the Protein(s) Expressed From This Construct. The top panel
shows the construction of the cys196dsI-a expression plasmid. In the middle panel, the distribution of the protein expressed
from this construct was examined by labeling transfected cells and immunoprecipitating furin proteins from cellular lysates
and conditioned medium, as indicated; as a control, parallel experiments were done using the original cys196dsI construct.
Lanes labeled I were immunoprecipitated from cells transfected with the cys196dsI construct. Lanes labeled I-a were
immunoprecipitated from cells transfected with the cys196dsI-a construct. Arrows indicate the positions of molecular weight
markers. The protein just above the 75 kDa marker is non-specifically immunoprecipitated from RPE.40 cells. In the bottom
panel, the pro-vWF processing activity of cells co-transfected with the cys196dsI-a and pro-vWF constructs was examined;
parallel co-transfections were done using the original cys196dsI construct and the pro-vWF construct. Samples of conditioned
medium from the transfected cells were collected 60 hr post transfection and the processing of pro-vWF analyzed by western
blotting. Lane 1 is a control, in which pro-vWF alone was expressed in RPE.40 cells. In Lanes 2 and 3 pro-vWF was
coexpressed in RPE.40 cells along with either the proteins produced from the original cys196dsI construct (Lane 2) or the
protein made from the cys196dsI-a construct (Lane 3). The arrowhead indicates the position of pro-vWF, while the arrow
indicates the position of mature vWF.
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biochemical basis for the lack of activity in the
mutant proteins. Amino acid 196 is located in
the heart of the catalytic domain of mammalian
furins, and the cysteine at position 196 is
conserved in all mammalian furins (5, 34-40).
Molecular modeling studies have led to the
hypothesis that either cys196 or cys198 forms a
disulfide bridge with cys226 (12). The disruption
of this disulfide bridge could seriously alter the
three dimensional configuration of the active
site, and therefore could impact the ability to
bind substrate and/or engage in catalysis. Our
data are consistent with this model, although
further studies are needed to conclusively say
this disulfide bridge is disrupted in the tyr196
furin. We can, however, unequivocally conclude
that cys196 plays some essential role in the
catalytic activity of furin, as we had postulated
(33).
Although the truncated cys196dsI and cys196dsII
proteins retain a wild type catalytic domain,
neither contains an intact Homo B domain. It
has been suggested that furin proteins lacking an
intact Homo B domain fail to fold into the
proper three dimensional configuration (42).
Other studies on mammalian furins truncated
into the Homo B domain suggest that the region
containing amino acids 449–469 of mature furin
is essential for catalytic activity, perhaps reflect-
ing a requirement for this region in the proper
folding of the protein (7, 31, 42). The furin
amino acid sequence encoded by the cys196dsI
cDNA terminates at position 454. The lack of
catalytic activity of this truncated molecule may
indicate that an amino acid necessary for proper
folding and activity is located between position
454 and 469; however, the presence of 19
intron-encoded amino acids at the carboxy
terminus of the cys196dsI protein introduces
another variable, and makes a definitive conclu-
sion about the importance of amino acids
454–469 somewhat problematic. The cys196dsII
protein is truncated at position 312, and, thus,
the lack of catalytic activity was expected.
We examined other characteristics of the
mutant proteins and compared these features to
those of the wild-type, cys196 furin. None of the
mutant proteins exhibited evidence of autocata-
lytic activity. This observation is consistent with
their inability to process pro-vWF. Others have
identified a mutant furin capable of autocatalysis
while exhibiting no catalytic activity versus
pro-vWF (42). In this mutant protein, Asn188, a
residue believed to be important in substrate
binding, was changed to an alanine residue by
site directed mutagenesis. The lack of catalytic
activity versus pro-vWF in this mutant enzyme
is presumably due to an inability to bind
substrate molecules. None of the mutant furins
we have examined appears to be like the Ala188
furin in this regard, as the lack of processing
activity versus pro-vWF correlates with a lack
of autocatalytic processing.
We also examined the glycosylation of the
mutant proteins. The tyrl96 furin did not acquire
endo-H resistance, indicating that no complex
oligosaccharides were attached to this protein.
This finding suggests that the tyr196 protein
remains in the endoplasmic reticulum, and is
consistent with reports showing that furin
molecules containing the pro-peptide remain in
this compartment (20, 23, 43). The glycosyla-
tion characteristics of the cys196dsI and cys196dsII
proteins proved somewhat more difficult to
interpret, and conclusions about their cellular
localization are more problematic. Truncated
furin proteins would not be expected to localize
in the TGN, as the carboxy terminus appears to
mediate this localization (24, 44–46), and
several truncated mammalian furins have been
shown to be secreted (7, 42). However, severely
truncated furins are not secreted; furin proteins
of at least 475 amino acids in length appear to be
secreted, while shorter furins (303 amino acids
or shorter) exhibit no evidence of secretion (7,
42). We found no evidence for secretion of the
cys196dsI protein, which is truncated at amino
acid position 454 but also contains 19 intron
coded amino acids at the carboxy terminus.
Interestingly, the cys196dsI protein did appear to
acquire endo-H resistance, suggesting this pro-
tein does move out of the endoplasmic reticu-
lum. That the cys196dsI protein was not secreted
was not surprising considering the results of
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others examining similar severely truncated
furin proteins (42). The glycosylation character-
istics of this protein, while somewhat unusual,
suggest it remains in the endoplasmic reticulum;
the apparently variable glycosylation we ob-
served may be a manifestation of the aberrant
nature and severe truncation of this protein.
Our initial co-expression experiments sug-
gested the cys196dsI protein was catalytically
active. We subsequently showed that this
activity was due to the presence of some
correctly spliced furin mRNAs being produced
and translated into full-length, catalytically
active furins. The correctly spliced mRNAs
arose when the intact intron contained within
our initial cys196dsI cDNA was properly excised.
Correct removal of the intron apparently occurs
only in a subset of the RNA population
transcribed from the cys196dsI-encoding plasmid,
and we have not yet established a mechanism to
explain why the intron is removed in only some
of the RNAs.
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